VisionTo be the leading refence laboratory in the GCC and the Middle East in localizing cutting edge clinical diagnostic technologies based on mass spectrometry and next generation sequencing, and to be the premier local partner for innovation and advancement in clinical and pharmaceutical research.MissionImprove patient outcome by localizing critical assays in region, henceforth deriving a drastic reduction in time of result to doctors, and consequently enhancing their medical decisions.Deliver the highest level of quality results by employing Gold Standard techniques, and adhering to the uppermost international accreditation standards.Provide access to local scientists the know-how to develop and train on cutting edge diagnostics technologies.Collaborate on purposeful innovation with academic, and pharmaceutical research institutions in the GCC for the advancement of science and the betterment of society.Build partnership with local hospitals and laboratories in the region with the aim to assist them inamelioratingthe quality of patient care. In early 2016, Amerispec Diagnostics was founded and a state-of-the art facility was set up to localize sent out clinical services in the United Arab Emirates to best support our partners in the Gulf States, and the Middle East region. With this investment, we were able to provide local access to these services, reduce substantially the Turn Around Time for these assays, and thus improving patient outcome. Given the uniqueness of these technologies and the know-how required to set up such facility, we recruited experienced scientists from the United States of America in the respective fields to successfully launch this venture and to best support the medical community and patients needs..